Table 2 Clinical characteristics of the patients. Characteristics of the patients included in the second phase (ESS ≥ 11 and/or cataplexy) are summarized in the following table
From: Exploring the presence of narcolepsy in patients with schizophrenia
Patients (n = 24) | |
|---|---|
Age (years) | 39.7 ± 10.3 (range 21–57) |
Age of onset psychiatric disorder (years) | 22.8 ± 7.5 (range, 12–44) |
Male gender (%) | 54.2 |
Body Mass Index (n) | 32.8 ± 5.6 (range, 20–43.7) |
Epworth Sleepiness Scale score (n) | 11.4 ± 4.1 (range, 2–18) |
Duration of EDS (years) | 16.8 ± 14.2 (range, 1–50) |
Possible cataplexy (n/%) | 6 (25) |
Hypnagogic/hypnopompic Hallucinations (n/%) | 5 (20.8) |
Sleep paralysis (n/%) | 5 (20.8) |
Estimated Nocturnal sleep amount (hours) | 9.7 ± 2 (range, 5–13.5) (14 patients slept ≥ 10 h/night) |
Nocturnal sleep fragmentation (≥2 awakenings/night) (%) | 1 (4.1) |
Refreshing short naps (%) | 0 (0) |
Circadian rhythm disorder | 1 patient had advanced sleep phase disorder 4 patients had delayed sleep phase disorder |
Snorers (n/%) | 12 (50) |
Witnessed apneas (n/%) | 6 (25) |
Previous diagnosis of OSAS (n/%) | 1 (4.1) |
Neuroleptic treatment (%) | 100 |
Benzodiazepine treatment (%) | 37.5 |
Antidepressant treatment (%) | 45.8 |
Antiepileptic treatment (%) | 54.2 |